Home/Filings/4/0001415889-22-005575
4//SEC Filing

Walsh Angela 4

Accession 0001415889-22-005575

CIK 0001818844other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 2:53 PM ET

Size

4.5 KB

Accession

0001415889-22-005575

Insider Transaction Report

Form 4
Period: 2022-05-23
Walsh Angela
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-05-23$4.58/sh+2,000$9,1503,000 total(indirect: By IRA)

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1
  • filerCIK 0001825987

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 2:53 PM ET
Size
4.5 KB